Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: business – Page 26

AI Explained: AI Agents Are Quietly Taking Over Everyday Tasks

Although UBTech is leaving 10% of work for humans in management, other AI tech is being specifically developed for that niche: OpenAI’s new framework, Swarm, allows AI agents to collaborate and independently execute complex tasks, potentially boosting business efficiency.

Artificial intelligence agents are everywhere, quietly reshaping industries and automating tasks we didn’t think possible a few years ago. Unlike basic automation, these AI agents can handle complex jobs, think independently and learn from their environment. The result? Healthcare, finance and logistics businesses are seeing rapid gains in efficiency — and, in some cases, doing away with manual work altogether.

What are AI agents exactly? They’re software programs that carry out specific tasks without constant supervision. Whether handling customer requests, diagnosing medical conditions or predicting market trends, AI agents are versatile workhorses. Instead of waiting for humans to input every command, these agents operate autonomously, reacting to real-time data and adjusting their actions accordingly.

Microsoft recently unveiled new AI tools allowing healthcare organizations to build customized AI agents for appointment scheduling, clinical trial matching, and patient triage. These agents are designed to streamline workflows and improve efficiency, helping healthcare providers manage workloads and enhance patient care.

“The New Chemotherapy”: Duo Oncology Introduces First Innovative Cancer-Fighting Nanomedicine in Over a Decade

Fortunately, the past decade has experienced a boom, with over 200 startups bringing novel cancer therapies—primarily antibodies, viruses, or cells—into clinical trials aiming to find alternatives to toxic chemotherapy. Despite these innovations, chemotherapy remains an essential yet toxic part of cancer care. In Pittsburgh, a small team of scientist-entrepreneurs and oncologists started meeting every Friday morning before work, collaborating to search for a new chemistry, one that could replace toxic chemotherapies. Their search soon focused on compelling research about novel ultra-small nanomedicine chemistry that carried potent drugs deep into solid tumors while sparing healthy organs.

This new nanomedicine chemistry fascinated Dr. Sam Rothstein, a scientist-entrepreneur with 20+ years of nanomedicine research experience spanning academia and industry. “We could make a real positive impact on patients,” says Rothstein. “We know that nanomedicines, which keep potent therapies out of healthy organs, improve quality of life. But this novel ultrasmall chemistry could go even further, saving lives by reaching remote cancer cells that current therapies can’t touch.”

Dr. Rothstein set to work building a new company, calling on connections made over a 10+-year career as a life science startup CEO and CSO, where he founded and grew two nanomedicine startups from academic discoveries. After months of market, regulatory, and business research, Duo Oncology was born.

Dr. Mehmood Khan, MD — CEO, Hevolution Foundation — Expanding Healthy Human Lifespan for All

Expanding Healthy Human Lifespan for All — Dr. Mehmood Khan, MD — CEO, Hevolution Foundation.

Dr. Mehmood Khan, MD is the Chief Executive Officer of Hevolution Foundation (https://www.hevolution.com/), a first of its kind non-profit organization that funds research through grants and provides investments in biotech to incentivize healthspan science across disciplines and borders for the benefit of all. Established by a Saudi Royal Decree, with its headquarters in Riyadh, with additional international hubs to support the expansion and execute the global mission, it’s vision is to expand healthy human lifespan for the benefit of all humanity.

Hevolution Foundation aims to be positioned as a global leader, catalyst, partner, and convener, to increase the number of scientists entering the field, to increase the investable opportunities in the field of aging, and to help shape the regulatory and government environment.

Dr. Khan also currently serves as the Executive Chairman of Life Biosciences Inc. where he joined the company in April 2019 as the Chief Executive Officer and Board Member. Life Biosciences was founded to advance scientific research and develop innovative new therapies to improve and extend healthy lives for everyone.

Dr. Khan previously served as Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo, a Fortune 50 company employing upwards of 250,000 employees across 22 brands. At PepsiCo, Dr. Khan played a pivotal role in the company’s global R\&D efforts to create breakthrough innovations in food, beverages, and nutrition, including the incorporation of healthier and more nutritious offerings across its portfolio. Dr. Khan also oversaw PepsiCo’s global sustainability initiatives based on the belief that success in business is inextricably linked to the sustainability of the world we share.

Continue reading “Dr. Mehmood Khan, MD — CEO, Hevolution Foundation — Expanding Healthy Human Lifespan for All” | >

Transforming Contract Management In Banking And Enterprises With Generative AI

At Impactsure Technologies, we’ve helped clients of banks generate guarantees and contracts through preapproved clauses in a matter of a few seconds without the need to go through a complex process of vetting that would have otherwise taken many days. It not only enhances the customer experience but also makes it easier to manage the processes efficiently. The clients are able to manage their contracts well, manage the content, ensure appropriate vetting and scrutiny are done effectively, manage the timelines, and incorporate the electronic signing options in a seamless way.

As contract management complexities continue to increase in the banking and enterprise sectors, the adoption of GenAI emerges as strategically crucial for organizations seeking to enhance operational efficiency, mitigate risks and maintain regulatory compliance. By harnessing the power of AI-driven automation, banks and enterprises can streamline contract processes, optimize resource utilization and confidently navigate the complicated legal landscape.

A combination of GenAI, NLP and ML represents a paradigm shift in contract management, empowering banks and enterprises to easily manage the complexities of the modern business environment with agility and resilience. By embracing AI-driven solutions, organizations can unlock new opportunities for growth, innovation and sustainable success in an increasingly competitive and rapidly evolving environment.

Google bets big on ‘mini’ nuclear reactors to feed its AI demands

“The grid needs new electricity sources to support AI technologies that are powering major scientific advances, improving services for businesses and customers, and driving national competitiveness and economic growth,” Google Senior Director for Energy and Climate Michael Terrell, said in a statement.

“This agreement helps accelerate a new technology to meet energy needs cleanly and reliably, and unlock the full potential of AI for everyone,” Terrell added.

Inside @ibm’s Quantum System Two, The World’s First Modular Utility Scale Quantum Computer

#ibm #heron #quantumcomputer #quantumphysics #softwareengineering #developers #programming #artificialintelligence #ai #neuralnetworks #machinelearning #explorepage #financialmarkets #cryptography #business #productdevelopment #researchanddevelopment #computerscience #qubit #engineering #technology #startups #science #mathematics #innovation #invention

No teachers, no homework: School solely uses AI to teach students

A school in Texas is revolutionizing the way students learn by going all-in on artificial intelligence. Its leaders are using the technology to educate students without the help of a traditional teacher. NBC’s Gadi Schwartz reports for TODAY.

» Subscribe to TODAY: / @today.

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage \& our original web series.

Connect with TODAY Online!
Visit TODAY’s Website: https://www.today.com/
Find TODAY on Facebook: / today.
Follow TODAY on Twitter: / todayshow.
Follow TODAY on Instagram: / todayshow.

» Stream TODAY All Day: https://www.today.com/allday.
About: TODAY All Day is a 24/7 streaming channel bringing you the top stories in news and pop culture, celebrity interviews, cooking, and more. All in one place.

#ai #parenting #school

Continue reading “No teachers, no homework: School solely uses AI to teach students” | >

How far till Longevity Escape Velocity?

They say aging is just a part of life, but have you ever wondered if it really has to be? What if getting older isn’t just something we accept but something we could actually treat?

In this riveting episode of Peak Human Labs Podcast, Dr. Sanjeev Goel, sits down with Dr. Aubrey de Grey, a trailblazing biomedical gerontologist and Chief Science Officer of the SENS Research Foundation. They dive deep into the revolutionary idea of treating aging as a medical condition. They explore how damage accumulates in our bodies over time and discuss the groundbreaking medical advancements that could extend our healthy lifespans. Dr. de Grey sheds light on the crucial need for investing in underfunded research and shares insights into the future of longevity science. Tune in and envision a future where health and longevity are not just aspirations but achievable realities!

Click https://dublinlongevitydeclaration.or… to sign in for Dublin Longevity Declaration.

In This Episode:

[00:00:00] Introduction to longevity research.
[00:00:51] Guest introduction.
[00:01:17] Personal connection.
[00:02:04] Dr. de Grey’s background.
[00:03:14] Early research stages.
[00:04:05] Understanding aging as a machine.
[00:05:22] Accumulated damage mechanism.
[00:06:15] Comprehensive medical control.
[00:07:13] Categories of damage.
[00:07:55] Wear and tear concept.
[00:09:20] Epigenetic changes discussion.
[00:11:31] Partial reprogramming concept.
[00:13:30] Addressing multiple mechanisms.
[00:14:31] Longevity escape velocity.
[00:15:43] Initial pushback on longevity ideas.
[00:17:51] Positive outlook on aging research.
[00:19:51] The future of longevity research.
[00:20:54] Funding disparities in research.
[00:21:10] Business models in longevity research.
[00:21:58] Combining existing therapies.
[00:23:47] Current longevity therapies.
[00:24:56] Caloric restriction vs. drugs.
[00:25:36] Dublin Longevity Declaration.
[00:26:39] Community building through conferences.
[00:28:09] Anticipating longevity breakthroughs.
[00:29:12] Access to longevity therapies.
[00:30:58] Epigenetic clocks and age reversal.
[00:32:24] Retroviruses and aging.
[00:34:56] Persistent viral infections.
[00:37:24] Hyperbaric oxygen therapy.
[00:37:49] Therapeutic blood exchange.
[00:39:37] Discussion on active ingredients.
[00:40:41] Bone marrow transplant experimentation.
[00:42:09] Health benefits of bone marrow transplants.
[00:43:05] Personal health practices.
[00:43:55] Advice for maximizing healthy lifespan.
[00:45:01] Microbiome and longevity.